Mbala-Kingebeni, PlacidePlacideMbala-KingebeniNguyen, Nam VNam VNguyenMwanza, Jean-ClaudeJean-ClaudeMwanzaCarag, JessicaJessicaCaragLinderman, SusanneSusanneLindermanFashina, TolulopeTolulopeFashinaKinganda, EddyEddyKingandaWawina-Bokalanga, TonyTonyWawina-BokalangaAziza, AmuriAmuriAzizaMakangara Cigolo, Jean ClaudeJean ClaudeMakangara Cigolo0000-0002-1791-2247Vakaniaki, Emmanuel HasivirweEmmanuel HasivirweVakaniakiAnta, YvonYvonAntaYango, JepsyJepsyYangoTshiani, OlivierOlivierTshianiKindrachuk, JasonJasonKindrachukLiesenborghs, LaurensLaurensLiesenborghsPeeters, MartineMartinePeetersDelaporte, EricEricDelaporteRimoin, Anne WAnne WRimoinHuggins, John WJohn WHugginsRiu-Rovira, ThereseThereseRiu-RoviraAhuka, Steve MSteve MAhukaMartin, James WJames WMartinCrozier, IanIanCrozierYeh, StevenStevenYehMuyembe, Jean-JacquesJean-JacquesMuyembe2025-05-092025-05-092025-04-09https://boris-portal.unibe.ch/handle/20.500.12422/210742This report describes the ocular manifestations in a cohort of patients with Clade I mpox evaluated in the Democratic Republic of the Congo (DRC) from 2007 to 2011, as well as the clinical course of a pediatric patient with mpox associated with ocular disease. Among 216 patients, ocular manifestations were observed in 8.3% of the patients, including conjunctivitis, eyelid lesions, eyelid swelling, eye pain, orbital swelling, keratitis, and corneal staphyloma. These findings highlight the broad spectrum of ocular manifestations with potential sight-threatening consequences in patients with mpox.enClade I monkeypox virusDemocratic Republic of the CongoMpoxconjunctivitiscorneal staphylomaeyelid edemakeratitisocular manifestationsarticle10.48620/879264029744910.1101/2025.04.07.25325069